Meta-analysis of the efficacy and safety of secukinumab in the treatment of moderate to severe psoriasis

Meta-analysis of the efficacy and safety of secukinumab in the treatment of moderate to severe psoriasis

Purpose: The purpose of this study is to evaluate the efficacy and safety of secukinumab in the treatment of moderate to severe psoriasis. Methods: This study conducted a comprehensive review using multiple databases, including PubMed, EMBASE, Cochrane Library, ISI Web of Knowledge, and Chinese data...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yanxia Cai, Shiyin Deng, Yaqi Luo, Liehua Deng
Format:	Article
Language:	English
Published:	AIP Publishing LLC 2025-01-01
Series:	AIP Advances
Online Access:	http://dx.doi.org/10.1063/5.0251460
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and safety of ustekinumab in the treatment of moderate to severe plaque psoriasis in Singapore
by: Wai Sze Agnes Chan, et al.
Published: (2023-07-01)

Long-Term efficacy and safety analysis of secukinumab in the treatment of pediatric generalized pustular psoriasis: a real-world study
by: Lu Xing, et al.
Published: (2025-12-01)

Successful Treatment of Pediatric Generalized Pustular Psoriasis with Secukinumab
by: Yu K, et al.
Published: (2025-01-01)

Assessing the Short-Term Efficacy and Safety of Guselkumab for Moderate-to-Severe Plaque Psoriasis: Meta-Analysis of Randomized Controlled Trials
by: Jing Yang, et al.
Published: (2020-01-01)

Shaping Treatment Expectation to Optimize Efficacy of Interleukin 17A Antagonist Secukinumab in Psoriasis Patients
by: Hölsken S, et al.
Published: (2025-01-01)

Network meta-analysis of efficacy and safety of drugs for the treatment of moderate to severe ulcerative colitis
by: Wenkai Zhang, et al.
Published: (2025-01-01)

Risankizumab Versus Secukinumab: A Real-World Efficacy and Cost per Responder Comparison in Patients With Psoriasis in Italy
by: Federico Pirro, et al.
Published: (2025-01-01)

Efficacy and Safety of Tripterygium Wilfordii Glycoside Tablets Combined with Acitretin Capsules in the Treatment of Moderate to Severe Plaque Psoriasis: A Randomized Controlled Trial
by: Qinghui Fu, et al.
Published: (2022-01-01)

Efficacy and safety of upadacitinib in the treatment of moderate-to-severe atopic dermatitis: A systematic review.
by: Dan-Jie Zhao, et al.
Published: (2024-01-01)

Efficacy and Safety of Risankizumab in Patients with Psoriasis Showing Suboptimal Response to Secukinumab or Ixekizumab: Results from a Phase 3b, Open-Label, Single-Arm (aIMM) Study
by: Richard B. Warren, et al.
Published: (2024-11-01)

Cross-sectional study of proteomic differences between moderate and severe psoriasis
by: Lingling Wu, et al.
Published: (2025-01-01)

Lack of reactivation of tuberculosis in patients with psoriasis treated with secukinumab in a real-world setting of latent tuberculosis infection
by: Matteo Megna, et al.
Published: (2022-07-01)

Safety and Efficacy of Anticoagulation in Patients with Cirrhosis: A Meta-Analysis
by: Huan Chen, et al.
Published: (2021-01-01)

Efficacy and Safety of Bevacizumab in the Treatment of Pterygium: An Updated Meta-Analysis of Randomized Controlled Trials
by: Yi Sun, et al.
Published: (2018-01-01)

Systematic review and bayesian network meta-analysis: comparative efficacy and safety of six commonly used biologic therapies for moderate-to-severe Crohn’s disease
by: Haohang Su, et al.
Published: (2025-01-01)

Sex Disparities of Health-related Quality of Life in Moderate to Severe Psoriasis: A Real-world Analysis from the Swiss Psoriasis Registry (SDNTT)
by: Ramtin Lichtenberger, et al.
Published: (2025-02-01)

Secukinumab in the treatment of psoriatic arthritis: efficacy and safety results through 3 years from the year 1 extension of the randomised phase III FUTURE 1 trial
by: Philip J Mease, et al.
Published: (2018-08-01)

Efficacy and safety of Janus kinase inhibitors in the treatment of psoriasis and psoriatic arthritis: An analysis of evidence from 2014 to 2022
by: Jiao Wang, et al.
Published: (2025-02-01)

Risk of Candida Infection and Serious Infections in Patients with Moderate-to-Severe Psoriasis Receiving Biologics: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Yue Feng, et al.
Published: (2022-01-01)

Portuguese consensus on first line treatment of moderate-to-severe psoriasis with a non-TNF inhibitor therapy – a delphi methodology
by: Tiago Torres, et al.
Published: (2025-12-01)

Clinical features, treatment, and prognosis of secukinumab-induced inflammatory bowel disease
by: Ronghui Li, et al.
Published: (2025-01-01)

Efficacy and safety of various drug combinations in treating plaque Psoriasis: A meta-analysis [version 2; peer review: 2 approved]
by: Nayak Snehasis, et al.
Published: (2025-01-01)

Recurrent NTM pulmonary disease despite avoidance of hot spring exposure in a plaque psoriasis patient treated with Secukinumab: a case report
by: Yixiao Wei, et al.
Published: (2025-01-01)

Efficacy and Safety of Ultrasound-Guided Radiofrequency Treatment for Chronic Pain in Patients with Knee Osteoarthritis: A Systematic Review and Meta-Analysis
by: Yuzhao Huang, et al.
Published: (2020-01-01)

Meta-analysis of Efficacy and Safety of Fire Acupuncture in Treatment of Ganglion Cyst
by: Yanan LIU, et al.
Published: (2019-08-01)

Psoriasis severity in moderate to severe psoriatic Greek patients routinely treated with systemic treatment: a cross-sectional and retrospective chart review study (CRYSTAL-Greece)
by: Dimitrios Rigopoulos, et al.
Published: (2025-12-01)

Efficacy and Safety of Adalimumab in Canadian Patients with Moderate to Severe Crohn’s Disease: Results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn’s DiseaSe (ACCESS) Trial
by: Remo Panaccione, et al.
Published: (2011-01-01)

Efficacy and Safety of Rituximab in the Treatment of Idiopathic Membranous Nephropathy: A Meta-Analysis
by: Huijuan Lu, et al.
Published: (2022-01-01)

Meta-analysis of efficacy and safety of pembrolizumab for the treatment of advanced or recurrent cervical cancer
by: Xue Zhang, et al.
Published: (2024-12-01)

Efficacy And Safety Of Low Dose Tofacitinib As Induction Therapy In Moderate To Severe Ulcerative Colitis: A Pilot Study
by: Sadia Ahmed, et al.
Published: (2024-12-01)

Secukinumab Treatment in Patients With Hidradenitis Suppurativa in Real-World Clinical Settings: A Multicenter Study
by: Ece Erbağcı, et al.
Published: (2025-01-01)

Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA Registry
by: Giuseppe Lopalco, et al.
Published: (2025-01-01)

Efficacy and Safety of Mesenchymal Stem Cells in Treatment of Complex Perianal Fistulas: A Meta-Analysis
by: Fang Cheng, et al.
Published: (2020-01-01)

Comparison the Efficacy of Fluconazole and Terbinafine in Patients with Moderate to Severe Seborrheic Dermatitis
by: Narges Alizadeh, et al.
Published: (2014-01-01)

Efficacy and safety of single-branched stent graft in the treatment of type B aortic dissection: a meta-analysis of cohort studies
by: Wenxiao Lin, et al.
Published: (2025-01-01)

The Safety of Systemic Treatments That Can Be Used for Geriatric Psoriasis Patients: A Review
by: Jillian W. Wong, et al.
Published: (2012-01-01)

The Effectiveness and Safety of Probiotic Supplements for Psoriasis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials and Preclinical Trials
by: Liuting Zeng, et al.
Published: (2021-01-01)

Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis
by: Tiago Torres, et al.
Published: (2024-04-01)

Efficacy of Chinese Herbal Medicine in the Treatment of Moderate-Severe Painful Diabetic Peripheral Neuropathy: A Retrospective Study
by: Yujiao Zheng, et al.
Published: (2019-01-01)

Efficacy and safety of topical versus intravenous tranexamic acid in spinal surgery: a systematic review and meta-analysis
by: Chengxin Xie, et al.
Published: (2025-01-01)